Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy
Na Liu, Liuqing Xu, Yingfeng Shi, et al.
Journal of Diabetes Research (2017) Vol. 2017, pp. 1-6
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Targeting the progression of chronic kidney disease
Marta Ruiz–Ortega, Sandra Rayego‐Mateos, Santiago Lamas, et al.
Nature Reviews Nephrology (2020) Vol. 16, Iss. 5, pp. 269-288
Closed Access | Times Cited: 698
Autophagy in Chronic Kidney Diseases
Tien‐An Lin, Victor Chien‐Chia Wu, Chao‐Yung Wang
Cells (2019) Vol. 8, Iss. 1, pp. 61-61
Open Access | Times Cited: 151
The New Biology of Diabetic Kidney Disease—Mechanisms and Therapeutic Implications
Yuliya Lytvyn, Petter Bjornstad, Daniël H. van Raalte, et al.
Endocrine Reviews (2019) Vol. 41, Iss. 2, pp. 202-231
Open Access | Times Cited: 115
Overexpression of Sirt6 promotes M2�macrophage transformation, alleviating renal injury in diabetic nephropathy
Li-Qiang Ji, Yifang Chen, Hongqiang Wang, et al.
International Journal of Oncology (2019)
Open Access | Times Cited: 92
MicroRNA-22 Promotes Renal Tubulointerstitial Fibrosis by Targeting PTEN and Suppressing Autophagy in Diabetic Nephropathy
Yingying Zhang, Siqi Zhao, Depei Wu, et al.
Journal of Diabetes Research (2018) Vol. 2018, pp. 1-11
Open Access | Times Cited: 88
SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in db/db Mice, a Model of Type 2 Diabetes
Anton I. Korbut, Iuliia Taskaeva, Н. П. Бгатова, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2987-2987
Open Access | Times Cited: 88
Exosomal miRNA-215-5p Derived from Adipose-Derived Stem Cells Attenuates Epithelial–Mesenchymal Transition of Podocytes by Inhibiting ZEB2
Juan Jin, Yunguang Wang, Li Zhao, et al.
BioMed Research International (2020) Vol. 2020, pp. 1-14
Open Access | Times Cited: 75
Changes of gut microbiota in diabetic nephropathy and its effect on the progression of kidney injury
Kedan Cai, Yanhong Ma, Fanghao Cai, et al.
Endocrine (2022) Vol. 76, Iss. 2, pp. 294-303
Open Access | Times Cited: 43
Paeoniflorin binds to VEGFR2 to restore autophagy and inhibit apoptosis for podocyte protection in diabetic kidney disease through PI3K-AKT signaling pathway
Xian Wang, Ling Jiang, Xue-qi Liu, et al.
Phytomedicine (2022) Vol. 106, pp. 154400-154400
Open Access | Times Cited: 40
Acute kidney injury in diabetes mellitus: Epidemiology, diagnostic, and therapeutic concepts
Yuan Gui, Zachary Palanza, Haiyan Fu, et al.
The FASEB Journal (2023) Vol. 37, Iss. 4
Open Access | Times Cited: 24
Pharmacological inhibition of autophagy by 3-MA attenuates hyperuricemic nephropathy
Jinfang Bao, Yingfeng Shi, Min Tao, et al.
Clinical Science (2018) Vol. 132, Iss. 21, pp. 2299-2322
Open Access | Times Cited: 74
Lysosome restoration to activate podocyte autophagy: a new therapeutic strategy for diabetic kidney disease
Wei Jing Liu, Yu Gan, Wei Huang, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 11
Open Access | Times Cited: 68
Research Progress on the Pathological Mechanisms of Podocytes in Diabetic Nephropathy
Lili Zhang, Zhige Wen, Lin Han, et al.
Journal of Diabetes Research (2020) Vol. 2020, pp. 1-15
Open Access | Times Cited: 56
LncRNA SOX2OT alleviates mesangial cell proliferation and fibrosis in diabetic nephropathy via Akt/mTOR-mediated autophagy
Ke Chen, Bo Yu, Jie Liao
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 51
The role and mechanism of butyrate in the prevention and treatment of diabetic kidney disease
Xi Cheng, Tingting Zhou, Yanqiu He, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 28
Crosstalk between autophagy and insulin resistance: evidence from different tissues
Asie Sadeghi, Maryam Niknam, Mohammad Amin Momeni‐Moghaddam, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 21
The role of autophagy in the treatment of type II diabetes and its complications: a review
Xuan Zhao, Luyao Bie, Dao-Ran Pang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 19
Circ-0000953 deficiency exacerbates podocyte injury and autophagy disorder by targeting Mir665-3p-Atg4b in diabetic nephropathy
Xueqi Liu, Ling Jiang, Han-xu Zeng, et al.
Autophagy (2023) Vol. 20, Iss. 5, pp. 1072-1097
Closed Access | Times Cited: 18
Lysophosphatidic Acid Signaling in Diabetic Nephropathy
Jong Eun Lee, Donghee Kim, Yoon Sin Oh, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 11, pp. 2850-2850
Open Access | Times Cited: 54
Hispidulin alleviates high-glucose-induced podocyte injury by regulating protective autophagy
Fengbo Wu, Sijia Li, Nan Zhang, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 104, pp. 307-314
Closed Access | Times Cited: 49
Spironolactone alleviates diabetic nephropathy through promoting autophagy in podocytes
Dan Dong, Tingting Fan, Yingshi Ji, et al.
International Urology and Nephrology (2019) Vol. 51, Iss. 4, pp. 755-764
Open Access | Times Cited: 46
ANGPTL2 regulates autophagy through the MEK/ERK/Nrf-1 pathway and affects the progression of renal fibrosis in diabetic nephropathy.
Haiquan Huang, Hai-Feng Ni, Kun‐Ling Ma, et al.
PubMed (2019) Vol. 11, Iss. 9, pp. 5472-5486
Closed Access | Times Cited: 38
Vitamin D Ameliorates Podocyte Injury by Enhancing Autophagy Activity in Diabetic Kidney Disease
Xiaoyi Zhang, Li Zhang, Yingzhen Wen, et al.
Kidney & Blood Pressure Research (2023) Vol. 48, Iss. 1, pp. 314-325
Open Access | Times Cited: 12
Ameliorative effect of montelukast against STZ induced diabetic nephropathy: targeting HMGB1, TLR4, NF-κB, NLRP3 inflammasome, and autophagy pathways
Ahmed Awad, Sally L. Elshaer, Rajashekhar Gangaraju, et al.
Inflammopharmacology (2023) Vol. 32, Iss. 1, pp. 495-508
Open Access | Times Cited: 12
Autophagy and Mitophagy in Diabetic Kidney Disease—A Literature Review
Alina Mihaela Stăniguţ, Liliana Tuţă, C Panà, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 806-806
Open Access
Page 1 - Next Page

Scroll to top